FDA approves a second Alzheimer’s drug that can slow the disease by several months

By The Associated Press

WASHINGTON (AP) — FDA approves a second Alzheimer’s drug that can slow the disease by several months.

Copyright 2024 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed without permission.